TraceLink announced its Russian compliance solution, providing companies with the ability to meet requirements for serialization, traceability, and compliance reporting for all pharmaceutical manufacturers.
The Wasdell Group, a leading partner to companies within the pharmaceutical, medical device and clinical trials industries, has launched its serialisation service ahead of the EU FMD and US DSCSA implementation deadlines.
Recipharm, a leading contract development and manufacturing organisation (CDMO) has announced the launch of its standalone serialisation service ahead of the introduction of the EU Falsified Medicines Directive (FMD).
The Expert Council of the Industrial Development Fund (IDF) has approved the first loan under the Drug Labeling program. The loan was provided to Polysan Scientific & Technological Pharmaceutical Company from St. Petersburg.
Prime Minister of the Russian Federation signed the Order No. 791-r of April 28, 2018, which approved the operation model for the system of labeling products by means of identification in the Russian Federation.
Industrial Development Fund (IDF) launched a new preferential lending program for the purchase of drug labeling equipment. The key feature of the program is that the company is not required to co-finance the project.